Izabela Rozenberg

1.2k total citations
18 papers, 933 citations indexed

About

Izabela Rozenberg is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Izabela Rozenberg has authored 18 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Izabela Rozenberg's work include Atherosclerosis and Cardiovascular Diseases (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Complement system in diseases (3 papers). Izabela Rozenberg is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Complement system in diseases (3 papers). Izabela Rozenberg collaborates with scholars based in Switzerland, United States and Japan. Izabela Rozenberg's co-authors include D H Farb, Felix C. Tanner, Thomas F. Lüscher, Christian M. Matter, Jan Borén, Burkhard Becher, Alexander Akhmedov, Mark Farrant, Michael Kurrer and Roméo Ricci and has published in prestigious journals such as Science, Blood and PLoS ONE.

In The Last Decade

Izabela Rozenberg

18 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Izabela Rozenberg Switzerland 15 355 322 186 159 100 18 933
Alexandra Moers Germany 15 482 1.4× 144 0.4× 138 0.7× 161 1.0× 161 1.6× 17 1.1k
Martin Vidgeon-Hart United Kingdom 15 261 0.7× 132 0.4× 145 0.8× 108 0.7× 114 1.1× 19 723
Victor Blanco United States 15 379 1.1× 133 0.4× 72 0.4× 147 0.9× 84 0.8× 23 922
Zhihua Qiu China 18 644 1.8× 239 0.7× 170 0.9× 357 2.2× 146 1.5× 43 1.3k
Celina García Mexico 16 517 1.5× 191 0.6× 64 0.3× 99 0.6× 107 1.1× 30 1.4k
Takatoshi Soga Japan 13 773 2.2× 172 0.5× 252 1.4× 237 1.5× 57 0.6× 21 1.5k
Takao Tashiro Japan 9 550 1.5× 231 0.7× 147 0.8× 203 1.3× 18 0.2× 20 1.8k
Changhai Tian United States 22 862 2.4× 107 0.3× 56 0.3× 176 1.1× 136 1.4× 38 1.3k
Nanae Nagata Japan 16 238 0.7× 68 0.2× 108 0.6× 82 0.5× 34 0.3× 48 739
Tal Nuriel United States 13 373 1.1× 103 0.3× 76 0.4× 167 1.1× 32 0.3× 21 1.1k

Countries citing papers authored by Izabela Rozenberg

Since Specialization
Citations

This map shows the geographic impact of Izabela Rozenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izabela Rozenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izabela Rozenberg more than expected).

Fields of papers citing papers by Izabela Rozenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izabela Rozenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izabela Rozenberg. The network helps show where Izabela Rozenberg may publish in the future.

Co-authorship network of co-authors of Izabela Rozenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Izabela Rozenberg. A scholar is included among the top collaborators of Izabela Rozenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izabela Rozenberg. Izabela Rozenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ando, Kiyoshi, Laimonas Griškevičius, Takayuki Ikezoe, et al.. (2023). P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI). HemaSphere. 7(S3). e17022e8–e17022e8. 1 indexed citations
2.
Kimball, Alexa B., Christian Loesche, Errol P. Prens, et al.. (2022). IL‐17A is a pertinent therapeutic target for moderate‐to‐severe hidradenitis suppurativa: Combined results from a pre‐clinical and phase II proof‐of‐concept study. Experimental Dermatology. 31(10). 1522–1532. 32 indexed citations
3.
Risitano, Antonio M., Alexander Röth, Juliette Soret, et al.. (2021). Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. The Lancet Haematology. 8(5). e344–e354. 69 indexed citations
4.
Jang, Jun‐Ho, Lily Wong, Bor‐Sheng Ko, et al.. (2021). 12-Month Analysis of a Phase 2 Study of Iptacopan (LNP023) Monotherapy for Paroxysmal Nocturnal Hemoglobinuria. Blood. 138(Supplement 1). 2173–2173. 4 indexed citations
5.
Kaul, Martin, Philip Jarvis, Izabela Rozenberg, et al.. (2020). First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology. 35(5). 1143–1151. 24 indexed citations
6.
Jacquemont, Sébastien, Laura Pacini, Aia Elise Jønch, et al.. (2018). Protein synthesis levels are increased in a subset of individuals with fragile X syndrome. Human Molecular Genetics. 27(12). 2039–2051. 48 indexed citations
7.
Mueller, Arne, Sébastien Jacquemont, Florian Hahne, et al.. (2016). Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome. Clinical Epigenetics. 8(1). 15–15. 15 indexed citations
8.
Akhmedov, Alexander, Izabela Rozenberg, Francesco Paneni, et al.. (2014). Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. European Heart Journal. 35(40). 2839–2848. 89 indexed citations
9.
Stämpfli, Simon F., Giovanni G. Camici, Stephan Sylvest Keller, et al.. (2013). Restraint stress enhances arterial thrombosisin vivo– role of the sympathetic nervous system. Stress. 17(1). 126–132. 18 indexed citations
10.
Rozenberg, Izabela, Pavani Mocharla, Pierre Rotzius, et al.. (2011). Deletion of L-Selectin Increases Atherosclerosis Development in ApoE−/− Mice. PLoS ONE. 6(7). e21675–e21675. 21 indexed citations
11.
Rozenberg, Izabela, Lucia Rohrer, Janin Hofmann, et al.. (2010). Histamine H1 Receptor Promotes Atherosclerotic Lesion Formation by Increasing Vascular Permeability for Low-Density Lipoproteins. Arteriosclerosis Thrombosis and Vascular Biology. 30(5). 923–930. 65 indexed citations
12.
Stämpfli, Simon F., Alexander Akhmedov, Cathérine Gebhard, et al.. (2010). Aging Induces Endothelial Dysfunction While Sparing Arterial Thrombosis. Arteriosclerosis Thrombosis and Vascular Biology. 30(10). 1960–1967. 26 indexed citations
13.
Schiene‐Fischer, Cordelia, Jan Steffel, Giovanni G. Camici, et al.. (2007). Cyclophilin A differentially activates monocytes and endothelial cells. Atherosclerosis. 197(2). 564–571. 32 indexed citations
14.
Tanner, Felix C., Bernd van der Loo, S. Shaw, et al.. (2007). Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery. Basic Research in Cardiology. 102(4). 308–317. 11 indexed citations
15.
Matter, Christian M., Izabela Rozenberg, Helen Greutert, et al.. (2006). Effects of Tacrolimus or Sirolimus on Proliferation of Vascular Smooth Muscle and Endothelial Cells. Journal of Cardiovascular Pharmacology. 48(6). 286–292. 91 indexed citations
16.
Ricci, Roméo, Grzegorz Sumara, Izabela Sumara, et al.. (2004). Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis. Science. 306(5701). 1558–1561. 227 indexed citations
17.
18.
Rozenberg, Izabela, et al.. (1990). Chronic agonist exposure induces down-regulation and allosteric uncoupling of the gamma-aminobutyric acid/benzodiazepine receptor complex.. Molecular Pharmacology. 37(1). 37–43. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra Moers Breakdown of academic impact, for papers by Martin Vidgeon-Hart Breakdown of academic impact, for papers by Victor Blanco Breakdown of academic impact, for papers by Zhihua Qiu Breakdown of academic impact, for papers by Celina García Breakdown of academic impact, for papers by Takatoshi Soga Breakdown of academic impact, for papers by Takao Tashiro Breakdown of academic impact, for papers by Changhai Tian Breakdown of academic impact, for papers by Nanae Nagata Breakdown of academic impact, for papers by Tal Nuriel
Rankless by CCL
2026